12 Health Care Stocks Moving In Thursday's Pre-Market Session

 

Gainers

  • AcelRx Pharmaceuticals ACRX stock increased by 61.1% to $0.38 during Thursday's pre-market session. The company's market cap stands at $55.7 million. The company's, Q2 earnings came out today.
  • T2 Biosystems TTOO shares rose 39.05% to $0.22. The market value of their outstanding shares is at $37.7 million.
  • aTyr Pharma LIFE stock increased by 35.12% to $5.04. The company's market cap stands at $141.4 million.
  • Kala Pharmaceuticals KALA stock moved upwards by 35.05% to $0.47. The company's market cap stands at $34.1 million. As per the news, the Q2 earnings report came out today.
  • Cyclacel Pharmaceuticals CYCC stock increased by 23.3% to $1.64. The market value of their outstanding shares is at $16.3 million. The company's, Q2 earnings came out yesterday.
  • Cingulate CING shares moved upwards by 19.39% to $1.97.

Losers

  • Athenex ATNX stock declined by 36.9% to $0.7 during Thursday's pre-market session. The company's market cap stands at $85.1 million.
  • Hyperfine HYPR stock fell 19.48% to $1.5. The market value of their outstanding shares is at $105.4 million. As per the news, the Q2 earnings report came out yesterday.
  • Invitae NVTA stock declined by 19.01% to $6.99. The company's market cap stands at $1.6 billion. The company's, Q2 earnings came out 2 days ago.
  • Landos Biopharma LABP shares fell 11.39% to $1.09. The company's market cap stands at $43.8 million.
  • ChromaDex CDXC shares declined by 10.2% to $1.85. The company's market cap stands at $126.4 million. As per the news, the Q2 earnings report came out yesterday.
  • Sanofi SNY stock decreased by 9.45% to $40.93. The market value of their outstanding shares is at $102.3 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!